Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults.
Journal: The lancet. HIV
Published: November 15, 2024
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults.
Journal: Infectious diseases and therapy
Published: June 26, 2024
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial.
Journal: Respiratory investigation
Published: March 06, 2024
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
Journal: The New England journal of medicine
Published: December 13, 2023
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.
Journal: The Journal of infectious diseases
Published: October 05, 2023
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination.
Journal: bioRxiv : the preprint server for biology
Published: October 02, 2023
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination.
Journal: Cell reports
Published: August 24, 2023
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial.
Journal: The Journal of infectious diseases
Published: June 26, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Journal: Science translational medicine
Published: April 19, 2023
Last Updated: 09/26/2026